Stay updated with breaking news from Embecta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Embecta (NASDAQ:EMBC – Get Free Report) and Teleflex (NYSE:TFX – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, analyst recommendations, dividends, earnings and profitability. Earnings & Valuation This table compares Embecta and Teleflex’s top-line […]
Embecta Corp. (NASDAQ:EMBC – Get Free Report) was the target of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 3,330,000 shares, an increase of 6.7% from the October 31st total of 3,120,000 shares. Currently, 5.9% of the shares of the company are short […]
Embecta (NASDAQ:EMBC – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $1.90-2.10 for the period, compared to the consensus EPS estimate of $1.94. The company issued revenue guidance of $1.085-1.105 billion, compared to the consensus revenue estimate of $1.11 billion. Embecta Stock Performance […]
Embecta (NASDAQ:EMBC – Get Free Report) posted its earnings results on Tuesday. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.19, MarketWatch Earnings reports. Embecta had a net margin of 6.28% and a negative return on equity of 20.56%. The firm had revenue of $281.90 million during the […]
Embecta Corp. (NASDAQ:EMBC – Get Free Report) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totalling 4,000,000 shares, a drop of 20.2% from the September 30th total of 5,010,000 shares. Based on an average trading volume of 623,900 shares, the short-interest ratio is […]